Dr. Anthony Fauci isn't 'particularly concerned' about the safety of Moderna coronavirus vaccine (cnbc.com)

cnbc.com
  • White House coronavirus advisor Dr. Anthony Fauci said Monday he is "not particularly concerned" about the safety risk of a potential coronavirus vaccine by Moderna, despite the fact that it uses new technology to fight the virus. 
  • The vaccine, which entered a large phase-three human trial Monday, uses messenger ribonucleic acid, or mRNA molecules, to provoke an immune response to fight the virus.
cnbc.com
Submitted by mo2 on Mon, 07/27/2020 - 20:58

Covid-19 vaccine probably won't be 'widely available' until several months into 2021, Fauci says (cnn.com)

cnn.com

(CNN) A Covid-19 vaccine likely won't be "widely available" in the US until "several months" into next year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said Friday.

"I think as we get into 2021, several months in, that you would have [a] vaccine that would be widely available to people in the United States," Fauci told the Washington Post's Bob Costa during a Post Live event.

cnn.com
Submitted by mo2 on Fri, 07/24/2020 - 20:33

America's daily virus death toll passes 1,000 again (politico.com)

politico.com

The United States on Tuesday recorded more than 1,000 daily deaths from the coronavirus for the first time since May, another grim sign the country is struggling to contain the pandemic six months after it emerged in the U.S.

The daily death toll from Covid-19 had been falling steadily for months after peaking at over 2,000 in mid-April, but deaths began trending upward again earlier this month as the virus stormed across the South and Southwest.

politico.com
Submitted by mo2 on Fri, 07/24/2020 - 20:23

U.S. agrees to pay Pfizer and BioNTech $2 billion for 100 million doses of coronavirus vaccine (cnbc.com)

cnbc.com
  • Under the agreement, the U.S. will get 100 million doses of the vaccine, if it works, and can acquire 500 million additional doses if needed.
  • German biotech firm BioNTech and U.S.-based Pfizer are jointly developing the vaccine.
  • HHS said Americans won't have to pay for it. 

The U.S.

cnbc.com
Submitted by mo2 on Wed, 07/22/2020 - 20:48

Global coronavirus cases exceed 15 million: Reuters tally (reuters.com)

reuters.com

SYDNEY/LONDON (Reuters) - Global coronavirus infections surged past 15 million on Wednesday, according to a Reuters tally, with the pandemic gathering pace even as countries remain divided in their response to the crisis.

In the United States, which has the highest number of cases in the world with 3.91 million infections, President Donald Trump warned: “It will probably, unfortunately, get worse before it gets better.”

reuters.com
Submitted by mo2 on Wed, 07/22/2020 - 20:29

Bay Area tech workers consider moving amid layoff fears (axios.com)

axios.com

More than half of tech workers in the Bay Area are concerned about being laid off or furloughed in the next six months, or their salaries hitting a plateau or dropping, according to a new report from Hired.

Why it matters: The tech industry has generally fared better than other sectors in the pandemic downturn, offering more chances to work from home and fewer layoffs. However, there are concerns that companies won't be willing to pay Bay Area salaries if remote workers decide to relocate to less expensive areas.

axios.com
Submitted by mo2 on Wed, 07/22/2020 - 20:29

US charges two Chinese spies for a global hacking campaign that targeted COVID-19 research (techcrunch.com)

techcrunch.com

U.S. prosecutors have charged two Chinese nationals, said to be working for China’s state intelligence bureau, for their alleged involvement in a massive global hacking operation that targeted hundreds of companies and governments for more than a decade.

techcrunch.com
Submitted by mo2 on Tue, 07/21/2020 - 20:29

Coronavirus: Oxford vaccine triggers immune response (bbc.com)

bbc.com

A coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response.

Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus.

The findings are hugely promising, but it is still too soon to know if this is enough to offer protection and larger trials are under way.

bbc.com
Submitted by mo2 on Tue, 07/21/2020 - 00:03

Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage (marketwatch.com)

marketwatch.com

This is the first time that investigational COVID-19 vaccines have been reported to have a T-cell response

Britain's Prince William, Duke of Cambridge (2L), wearing PPE (personal protective equipment), of a face mask or covering, eye protection and an overall as a precautionary measure against spreading COVID-19, meets scientists including Christina Dold (R) during a visit to the manufacturing laboratory where a
marketwatch.com
Submitted by mo2 on Mon, 07/20/2020 - 00:09
Subscribe to